{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:24:36Z","timestamp":1787862276897,"version":"build-2784847793"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008376","name":"Helsingin ja Uudenmaan Sairaanhoitopiiri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007797","name":"Helsingin Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016332","name":"Medical Research Center Oulu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To study the predictive value of autoantibodies for type 1 (T1DM) and type 2 (T2DM) diabetes morbidity after gestational diabetes (GDM) in a 23-year follow-up study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Prospective population-based cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We studied 391 women with GDM, and 391 age- and parity-matched controls, who delivered in 1984\u20131994. Four autoantibodies were analysed in first-trimester blood samples: islet cell autoantibodies (ICAs), glutamic acid decarboxylase autoantibodies (GADAs), insulin autoantibodies (IAAs) and insulinoma-associated antigen-2 autoantibodies (IA-2As). Two follow-up questionnaires (1995\u20131996, 2012\u20132013) were sent to assess development of T1DM and T2DM. Predictive value of autoantibodies and clinical factors were analysed by conditional linear regression and ROC analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Single autoantibody positivity was detected in 12% (41\/342) of the GDM cohort and in 2.3% (8\/353) of the control cohort. In the GDM cohort, 2.6% (9\/342) tested positive for two autoantibodies and 2.3% (8\/342) for three autoantibodies, whereas only one subject in the control cohort had two autoantibodies. ICA positivity was found in 12.5% of the cases, followed by GADA (6.0%), IA-2A (4.9%) and IAA (1.2%). In the control cohort, GADA positivity was found in 1.4%, IA-2A in 0.8%, IAA in 0.6%, and ICA in 0.3% of the subjects. Detection of ICA, GADA and\/or IA-2A autoantibodies decreased T1DM-free survival time and time to diagnosis. All subjects with three positive autoantibodies developed T1DM within seven years from the GDM pregnancy. Development of T2DM after GDM occurred independent of autoantibody positivity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Development of T1DM can be reliably predicted with GADA and ICA autoantibodies during early pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2023.1286375","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T04:03:54Z","timestamp":1703045034000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Autoantibodies predict type 1 diabetes after gestational diabetes \u2013 a 23-year cohort study"],"prefix":"10.3389","volume":"14","author":[{"given":"Kaisu","family":"Luiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maaria","family":"Auvinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Auvinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Jokelainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkka","family":"J\u00e4rvel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Knip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha S.","family":"Tapanainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200524531","article-title":"Gestational diabetes mellitus","volume":"115","author":"Buchanan","year":"2005","journal-title":"J Clin Invest"},{"key":"B2","doi-asserted-by":"publisher","first-page":"782","DOI":"10.4239\/wjd.v6.i6.782","article-title":"Gestational diabetes mellitus: An update on the current international diagnostic criteria","volume":"6","author":"Agarwal","year":"2015","journal-title":"World J Diabetes"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411243312107","article-title":"The pathogenesis of insulin-dependent diabetes mellitus","volume":"331","author":"Epstein","year":"1994","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2009.04.004","article-title":"Diabetes related autoimmunity in gestational diabetes mellitus: is it important","volume":"19","author":"Lapolla","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2011.10.037","article-title":"HLA-DQB1 genotypes and islet cell autoantibodies against GAD65 and IA-2 in relation to development of diabetes post partum in women with gestational diabetes mellitus","volume":"95","author":"Papadopoulou","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-018-0830-3","article-title":"Presence of diabetes-specific autoimmunity in women with gestational diabetes mellitus (GDM) predicts impaired glucose regulation at follow-up","volume":"41","author":"Cossu","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2015.11.001","article-title":"IgG4 subclass glutamic acid decarboxylase antibodies (GADA) are associated with a reduced risk of developing type 1 diabetes as well as increased C-peptide levels in GADA positive gestational diabetes","volume":"162","author":"Dereke","year":"2016","journal-title":"Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1477-7827-6-24","article-title":"Autoimmunity in gestational diabetes mellitus in Sardinia: a preliminary case-control report","volume":"6","author":"Murgia","year":"2008","journal-title":"Reprod Biol Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb02983.x","article-title":"Low frequency of autoantibodies to islet cell, glutamic acid decarboxylase, and second-islet antigen in patients with gestational diabetes mellitus: a follow-up study","volume":"958","author":"Lapolla","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2001.112394","article-title":"Postpartum metabolism and autoantibody markers in women with gestational diabetes mellitus diagnosed in early pregnancy","volume":"184","author":"Bartha","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0157","article-title":"Presence of GAD antibodies during gestational diabetes mellitus predicts type 1 diabetes","volume":"30","author":"Nilsson","year":"2007","journal-title":"Diabetes Care"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2337\/diab.46.9.1459","article-title":"Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study","volume":"46","author":"F\u00fcchtenbusch","year":"1997","journal-title":"Diabetes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050578","article-title":"GAD65 autoantibodies in women with gestational or insulin dependent diabetes mellitus diagnosed during pregnancy","volume":"39","author":"Petersen","year":"1996","journal-title":"Diabetologia"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1994.tb02035.x","article-title":"Prevalence and predictive value of islet cell antibodies and insulin autoantibodies in women with gestational diabetes","volume":"11","author":"Damm","year":"1994","journal-title":"Diabetes Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.29.03.06.dc05-1118","article-title":"Gestational diabetes identifies women at risk for permanent type 1 and type 2 diabetes in fertile age: Predictive role of autoantibodies","volume":"29","author":"J\u00e4rvel\u00e4","year":"2006","journal-title":"Diabetes Care"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05215-3","article-title":"Type 1 and type 2 diabetes after gestational diabetes: a 23 year cohort study","volume":"63","author":"Auvinen","year":"2020","journal-title":"Diabetologia"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.963","article-title":"The prevalence of GAD antibodies in Korean women with gestational diabetes mellitus and their clinical characteristics during and after pregnancy","volume":"25","author":"Yu","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119879","article-title":"Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group","volume":"101","author":"Kulmala","year":"1998","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2003.00721.x","article-title":"Clinical characteristics and outcome of pregnancy in women with gestational hyperglycaemia with and without antibodies to beta-cell antigens","volume":"20","author":"Bo","year":"2003","journal-title":"Diabetes Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb02987.x","article-title":"Women diagnosed with gestational diabetes mellitus do not carry antibodies against minor islet cell antigens","volume":"958","author":"Balaji","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"B21","article-title":"Autoimmune markers of diabetes in diabetic pregnancy","volume":"33","author":"Fallucca","year":"1997","journal-title":"Ann Ist Super Sanita"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)90650-9","article-title":"Prevalence of antibodies to glutamic acid decarboxylase in women who have had gestational diabetes","volume":"173","author":"Beischer","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3109\/08916939008993382","article-title":"Increased interleukin 2 receptor expression in post-gestational women: relationship to impaired glucose tolerance and islet cell antibodies in pregnancy","volume":"7","author":"O\u2019brien","year":"1990","journal-title":"Autoimmunity"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199708)14:8<678::AID-DIA451>3.0.CO;2-F","article-title":"Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women","volume":"14","author":"Whittingham","year":"1997","journal-title":"Diabetes Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2174\/1573399813666170502110559","article-title":"Anti-islet cell antibodies in a sample of Egyptian females with gestational diabetes and its relation to development of type 1 diabetes mellitus","volume":"14","author":"Amer","year":"2018","journal-title":"Curr Diabetes Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"850","DOI":"10.4239\/wjd.v6.i6.850","article-title":"Diabetes mellitus: The epidemic of the century","volume":"6","author":"Kharroubi","year":"2015","journal-title":"World J Diabetes"},{"key":"B27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2337\/diacare.25.1.68","article-title":"Screening for MODY mutations, GAD antibodies, and type 1 diabetes\u2013associated HLA genotypes in women with gestational diabetes mellitus","volume":"25","author":"Weng","year":"2002","journal-title":"Diabetes Care"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2005.01438.x","article-title":"Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients","volume":"22","author":"Damanhouri","year":"2005","journal-title":"Diabetes Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2007.01.011","article-title":"Prevalence of GAD autoantibodies in Brazilian women with previous gestational diabetes","volume":"78","author":"Ferraz","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.4.1199","article-title":"Diabetes and abnormal glucose tolerance in women with previous gestational diabetes","volume":"26","author":"Albareda","year":"2003","journal-title":"Diabetes Care"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12629","article-title":"Zinc transporter 8 autoantibodies: what is their clinical relevance in gestational diabetes","volume":"32","author":"Rudland","year":"2015","journal-title":"Diabetes Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-0932-7","article-title":"The prevalence and predictive value of the SLC30A8 R325W polymorphism and zinc transporter 8 autoantibodies in the development of GDM and postpartum type 1 diabetes","volume":"53","author":"Dereke","year":"2016","journal-title":"Endocrine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1210\/jc.2009-1365","article-title":"Clinical applications of diabetes antibody testing","volume":"95","author":"Bingley","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050968","article-title":"Comparison of a novel micro-assay for insulin autoantibodies with the conventional radiobinding assay","volume":"41","author":"Naserke","year":"1998","journal-title":"Diabetologia"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.6285","article-title":"Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children","volume":"309","author":"Ziegler","year":"2013","journal-title":"JAMA"},{"key":"B36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12016-014-8461-8","article-title":"Clinical recommendations for the use of islet cell autoantibodies to distinguish autoimmune and non-autoimmune gestational diabetes","volume":"50","author":"Haller-Kikkatalo","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-019-0373-4","article-title":"Testing for type 1 diabetes autoantibodies in gestational diabetes mellitus (GDM): Is it clinically useful","volume":"19","author":"Incani","year":"2019","journal-title":"BMC Endocr Disord"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0690-4","article-title":"A high incidence of type 1 diabetes and an alarming increase in the incidence of type 2 diabetes among young adults in Finland between 1992 and 1996","volume":"50","author":"Lammi","year":"2007","journal-title":"Diabetologia"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1286375\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T04:03:58Z","timestamp":1703045038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1286375\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":38,"alternative-id":["10.3389\/fendo.2023.1286375"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1286375","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,20]]},"article-number":"1286375"}}